Abstract
The aim of the study was to critically examine existing data on the contribution of
gap junctions to the function of the female reproductive tract and their role in cancer
and benign gynecologic disease such as uterine leiomyomas and to evaluate the potential
for clinical applications of gap junction intercellular communication (GJIC) in the
treatment of diseases of the female reproductive tract. Gap junction proteins are
present in all organs of the female reproductive tract. GJIC is vital to folliculogenesis,
embryo implantation, and vascular changes associated with pregnancy and synchronization
of uterine contractions of parturition. Loss of GJIC is associated with malignancy,
and therapeutic restoration of GJIC reduces tumor growth and reverses chemotherapy
resistance. GJIC is critical for various cell and tissue functions including the function
of the female reproductive tract. Exploitation of the properties of GJIC may lead
to novel treatments for both benign and malignant gynecologic diseases. GJIC is critical
for various cell and tissue functions including specialized functions of the female
reproductive tract and potential maintenance of the benign behavior of uterine leiomyomas.
Keywords
gap junctions - connexin - intercellular communication - leiomyomas